Pharmafile Logo

Communiqué Awards 2016: Excellence in Communication of Survey or Market Research Data

July 13, 2016 | Communiqué Awards, Lucid 

The winning programme – Treating beyond symptoms in IBD: The Steroid Assessment Tool.

Our approach to medical education is really helping to improve patient outcomes and change lives.

Inflammatory bowel disease (IBD) affects more than 250,000 patients in the UK. Treatment strategies have progressed to treating beyond the symptoms of IBD, aiming to reduce mucosal inflammation, sustain remission and prevent bowel damage. 

Steroids have a place in the treatment pathway but do not sustain remission and are associated with significant side effects.The European Crohn’s and Colitis Organisation (ECCO) defines appropriate steroid use and recommends an exit strategy for steroid-dependent patients. However, gastroenterologists are not aware that inappropriate steroid use occurs in their own clinical practice.

Using a simple digital tool, UK experts audited their own practice and were surprised to see high steroid use among their patients. The expert group became advocates for change, motivated to share their data, targeting more than 300 UK HCPs with high steroid use, which comprises approximately 22% of UK IBD clinicians. Awareness of inappropriate steroid use, and the changes driven by the self-realisation of the need to optimise steroids, have the potential to impact the care delivered to over 50,000 UK IBD patients.


This content was provided by Lucid Group Communications Limited

Company Details

 Latest Content from  Lucid Group Communications Limited 

The Lucid Winter Summit 2016

Lucid Group put their skates on this year to celebrate an outstanding year’s performance at the Lucid Winter Summit at Somerset House, London.  Lucid Group enter their tenth year of...

2017: Medical education that improves value and outcomes for patients

In December’s Issue of PME, two of Lucid’s senior management team – Shula Sarner and Tanya Goodyear – consider how medical education will evolve in 2017.   They discuss industry...

Lucid Group kick off their Winter Festival

The start of December not only signalled the official calendar countdown to Christmas, but also marked the official launch of the Lucid Winter Festival, which culminates in the Winter Summit...

Leading Edge expands their senior medical writing team

Leading Edge, part of the Lucid Group specialising in strategic health communications and medical education, has bolstered its senior medical writing team with the new appointment of Jennifer (Jennie) Badger. Jennie...

Lucid win PMEA Support Agency of the Year 2016

Last night the Lancaster London Hotel hosted the annual PMEA awards. These awards recognise and commend companies and programmes demonstrating excellence, best practice and innovation in improving patient outcomes on...

Lucid strengthens its creative services department

There’s no slowing down for Lucid Group as it completes its first decade of trading early next year. In parallel with the recent appointments in its senior leadership team, Lucid...

Changing behaviour: putting theory into practice

In the November issue of PME, Madeleine Tye (senior account manager at Lucid Group) discusses Lucid’s approach to medical education. Lucid employs the outcomes of research into behavioural science in...

Tajinder’s #LucidLife

Medical writers are like gold dust, so when we find talented writers with great experience,we offer a tailor-made package.Are you a world-class medical writer?Do you like the look of Tajinder’s...

Fiona’s #LucidLife

Meet Fiona, a medical writer.She told us what she wanted, and we did the rest.We believe that medical writers are like gold dust; so when we find talent, we do...

Lucid Group: What medical communications means to us

Katherine Duxbury, Scientific Director at Lucid, explains what medical communications means to Lucid: What we do, how we do it and what makes us different.